MSB 2.10% $1.17 mesoblast limited

Ann: Phase 3 Trial in COVID-19 ARDS Surpasses 50% Enrollment, page-355

  1. 5,074 Posts.
    lightbulb Created with Sketch. 569
    big phrama with bigger pockets, Media in their big pockets.. and of course connection with those in the world of politics.... trump has mates in Gilead,
    since joining these posts only a fewmonths ago, and my research it has become very obvious that big phrama has a big voice and even that translates to the Australia Gov, have seen many products that the Gov will tend towards the big mouths, Remdevisir is the treatment of choice here although it doesn't work that well- and was before any phrase 3 trials..
    They are only are in the mode of "'seen to be doing something" not really fully investigating some products.
    I doubt the labour or other are doing much better as they don't seem to doing or daying much as a better way in alternatives... is it that Government have invested so much in a particular vein and not wanting to look in another direction for fear of looking bad- a treatment of whatever that is cheaper and works- yet has little voice.


 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.17
Change
-0.025(2.10%)
Mkt cap ! $1.330B
Open High Low Value Volume
$1.18 $1.22 $1.15 $6.344M 5.404M

Buyers (Bids)

No. Vol. Price($)
1 8683 $1.16
 

Sellers (Offers)

Price($) Vol. No.
$1.17 32999 1
View Market Depth
Last trade - 16.10pm 15/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.